Due Diligence in Pharmaceutical Industry: Performing an Industrial Due Diligence with a CDMO as a Target Company

Presentation

Our client, an investment fund, positioned as a potential buyer of a pharmaceutical subcontractor.

KEPLER carries out an industrial and supply chain diagnostics with a teams maturity assessment and a challenge of the considered CAPEX in the context of the Business Plan.

Context

A pharmaceutical group wants to carry out a carve-out operation for a CDMO activity (pharmaceutical subcontractor)
Several potential buyers among which investment funds

Objective(s)

Category: Securing the Business Plan

Building an industrial and supply chain report allowing:

Fund management to validate the industrial maturity of the target company and its development plan
Financial advisors to build the business plan & validate the OPEX / CAPEX strategy
Different banks to finance the operation

The report should contain:

Industrial and supply chain diagnostics
Team maturity assessment
CAPEX challenge planned in the coming years
Improvement areas
Assessment of potential gain sources (EBITDA, CASH, CAPEX)

Our role as an operating partner allowed investment funds to secure their acquisition while identifying sources of additional gains.
After that, our support allowed to achieve ambitious objectives.
Lionel Muller, Partner

COMPLETE VERSION

Discover the methodology, tools and results supporting this business case

Private Equity Referent

Lionel Muller

President

Lionel graduated from Ecole Centrale de Lyon as an engineer and began his career at PSA (now Stellantis Group) in product-process optimization and procurement. He was appointed at the…

Lionel Muller

Lionel Muller

President

Lionel graduated from Ecole Centrale de Lyon as an engineer and began his career at PSA (now Stellantis Group) in product-process optimization and procurement. He was appointed at the executive board in 2000 where he managed performance projects on procurement and operations. Lionel then joined the consulting industry. He is on of the founders of KEPLER where he specializes in the Automotive, Health, Energy and Private Equity sectors as President of the group.